Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 03, 2022

SELL
$187.54 - $223.02 $151,532 - $180,200
-808 Reduced 22.77%
2,740 $559,000
Q1 2022

Apr 12, 2022

SELL
$193.77 - $244.14 $322,239 - $406,004
-1,663 Reduced 31.91%
3,548 $748,000
Q4 2021

Jan 18, 2022

SELL
$223.92 - $287.77 $517,926 - $665,612
-2,313 Reduced 30.74%
5,211 $1.25 Million
Q3 2021

Oct 13, 2021

BUY
$282.99 - $369.05 $1,414 - $1,845
5 Added 0.07%
7,524 $2.13 Million
Q2 2021

Jul 21, 2021

BUY
$259.0 - $414.71 $477,855 - $765,139
1,845 Added 32.52%
7,519 $2.6 Million
Q1 2021

Apr 12, 2021

SELL
$242.95 - $284.63 $172,251 - $201,802
-709 Reduced 11.11%
5,674 $1.59 Million
Q4 2020

Jan 28, 2021

BUY
$236.26 - $355.63 $184,755 - $278,102
782 Added 13.96%
6,383 $1.56 Million
Q3 2020

Oct 08, 2020

SELL
$264.77 - $305.71 $14,827 - $17,119
-56 Reduced 0.99%
5,601 $1.59 Million
Q2 2020

Jul 13, 2020

SELL
$258.66 - $342.55 $36,729 - $48,642
-142 Reduced 2.45%
5,657 $1.51 Million
Q1 2020

Apr 07, 2020

SELL
$268.85 - $341.04 $139,264 - $176,658
-518 Reduced 8.2%
5,799 $1.84 Million
Q4 2019

Jan 13, 2020

SELL
$220.06 - $304.07 $251,968 - $348,160
-1,145 Reduced 15.34%
6,317 $1.88 Million
Q3 2019

Oct 09, 2019

BUY
$217.44 - $243.88 $90,455 - $101,454
416 Added 5.9%
7,462 $1.74 Million
Q2 2019

Jul 23, 2019

BUY
$219.29 - $241.72 $231,789 - $255,498
1,057 Added 17.65%
7,046 $1.65 Million
Q1 2019

Apr 10, 2019

SELL
$216.71 - $338.96 $54,827 - $85,756
-253 Reduced 4.05%
5,989 $1.42 Million
Q4 2018

Jan 09, 2019

BUY
$278.5 - $352.75 $26,457 - $33,511
95 Added 1.55%
6,242 $1.88 Million
Q3 2018

Oct 10, 2018

SELL
$293.51 - $383.83 $18,491 - $24,181
-63 Reduced 1.01%
6,147 $2.17 Million
Q2 2018

Jul 12, 2018

BUY
$257.52 - $306.91 $25,494 - $30,384
99 Added 1.62%
6,210 $1.8 Million
Q1 2018

May 11, 2018

BUY
$260.13 - $367.91 $985,372 - $1.39 Million
3,788 Added 163.07%
6,111 $1.67 Million
Q4 2017

Jan 17, 2018

BUY
$307.64 - $344.58 $714,647 - $800,459
2,323
2,323 $740,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Chicago Trust CO Na Portfolio

Follow Chicago Trust CO Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Trust CO Na, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Trust CO Na with notifications on news.